Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock

A sign with the company logo outside the headquarters of Eli Lilly and Company in Indianapolis,…

Abbott launches its first over-the-counter continuous glucose monitor in the U.S.

A man wearing Abbott’s Lingo biosensor. Courtesy of Abbott Abbott Laboratories announced Thursday its over-the-counter continuous…

Dexcom launches first over-the-counter continuous glucose monitor. Here’s what it’s like

Zoom In IconArrows pointing outwards User wearing Stelo CGM from Dexcom. Courtesy of Dexcom Dexcom on…

Jim Cramer looks at reasons for the market decline and provides new views on 3 stocks

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon…

We’re encouraged by Abbott stock trading but discouraged by moves in Honeywell

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon…

Jim Cramer’s advice on Abbott Labs stock after a nearly $500 million baby formula verdict

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20…

An ugly earnings report from a competitor is good news for Abbott Labs

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20…

FDA approves two new Abbott over-the-counter continuous glucose monitors

Abbott Chairman of the Board and CEO Robert B. Ford delivers a keynote address at CES…

We’re encouraged by an activist’s willingness to buy an Abbott rival, look past baby formula suits

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon…

Abbott Labs’ surprise guidance bump is a major positive for its shareholders

Abbott Laboratories delivered a top and bottom line beat Wednesday and surprised investors by raising its…

Newseum Global